- Home
- / Kaleido
Kaleido
Total Funding
$22.2 M
Kaleido Summary
Company Summary
- Overview
- Kaleido is an insulin pump therapy designed by ViCentra. It uses micro-pulse technology to deliver consistent and reliable dosing of insulin.
- Type
- Private
- Status
- Active
- Founded
- 2013
- HQ
- Utrecht, NL | view all locations
- Cybersecurity rating
Table of Contents
Key People
Tim Oakes, CTO and Co-Founder
Jorrit Kelderman, CFO
Jan Keltjens, Chairman of the Board
